C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients

American Journal of Physiology - Endocrinology and Metabolism

Volumn 286, Issue 1 49-1, 2004, Pages

  Johansson, Bo Lennart ^a,d   Sundell, Jan ^b   Ekberg, Karin ^a   Jonsson, Cathrine ^a   Seppänen, Marko ^c   Raitakari, Olli ^b   Luotolahti, Matti ^c   Nuutila, Pirjo ^b   Wahren, John ^a   Knuuti, Juhani ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Universität Turku   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Echocardiography; Myocardial blood flow; Positron emission tomography; Rate pressure product

Indexed keywords

ADENOSINE; C PEPTIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DRUG EFFECT; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BLOOD FLOW; HEMODYNAMICS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL;

EID: 9144264197     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00236.2003     Document Type: Article

References (35)

1. Alenius S and Ruotsalainen U. Bayesian image reconstruction for emission tomography based on median root prior. Eur J Nucl Med 24: 258-265, 1997.
2. Arnquist H, Olsson P, and von Schenk H. Free and total insulin determined after precipitation with polyethylene glycol: analytic characteristics and effect of sample handling and storage. Clin Chem 33: 93-96, 1987.
3. Buus N, Bottcher M, Hemansen F, Sander M, Nielsen T, and Mulvany M. Influence of nitric oxide synthase and adrenergic inhibition on adenosine-induced myocardial hyperemia. Circulation 104: 2305-2310, 2001.
4. Di Carli M, Bianco-Batlles D, Landa M, Kazmers A, Groehn H, Muzik O, and Grunberger G. Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation 100: 813-819, 1999.
5. Despres J, Lamarche B, Mauriege P, Cantin B, Dagenais G, Moorjani S, and Lupien P. Hyperinsulinemia as an independent risk factor for ischemic heart disease. New Engl J Med 334: 952-957, 1996.
6. De Vriese A, Verbeuren T, Van de Voorde J, Lameire N, and Vanhoutte P. Endothelial dysfunction in diabetes. Br J Pharmacol 130: 963-974, 2000.
7. Feigenbaum H. Echocardiography (5th ed.). Baltimore, MD: William & Wilkins, 1994, p. 144, 658-683.
8. Fernqvist-Forbes E, Johansson BL, and Eriksson M. Effects of C-peptide on forearm blood flow and brachial artery dilatation in patients with type 1 diabetes. Acta Physiol Scand 172: 159-165, 2001.
9. Hansen A, Johansson BL, Wahren J, and Bibra von H. C-peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes. Diabetes 51: 3077-3082, 2002.
10. Iida H, Rhodes C, de Silva R, Araujo L, Bloomfield P, Lammertsma A, and Jones T. Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. J Nucl Med 33: 1669-1677, 1992.
11. Iida H, Takahashi A, Tamura Y, Ono Y, and Lammertsma A. Myocardial blood flow: comparison of oxygen-15-water bolus injection, slow infusion and oxygen-15-carbon dioxide slow inhalation. J Nucl Med 36: 78-85, 1995.
12. Jensen J and Messina E. C-peptide induces a concentration-dependent dilation of skeletal muscle arterioles only in presence of insulin. Am J Physiol Heart Circ Physiol 276: H1223-H1228, 1999.
13. Jeppson J, Jerntorp P, Sundkvist G, Englund H, and Nylund V. Measurements of hemoglobin A1c by a new liquid-chromatographic assay: methodology, clinical utility, and relation to glucose tolerance evaluated. Clin Chem 32: 1867-1872, 1986.
14. Johansson B-L, Borg K, Fernqvist-Forbes E, Kernell A, Odergren T, and Wahren J. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type 1 diabetes-a three-month study. Diabet Med 17: 181-189, 2000.
15. Johansson B-L, Borg K, Fernqvist-Forbes E, Odergren T, Remahl S, and Wahren J. C-peptide improves autonomic nerve function in IDDM patients. Diabetologia 39: 687-695, 1996.
16. Johansson B-L, Linde B, and Wahren J. Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of Type 1 (insulin-dependent) diabetic patients. Diabetologia 35: 1151-1158, 1992.
17. Johansson B-L and Pernow J. C-peptide potentiates the vasoconstrictor effect of neuropeptide Y in insulin dependent diabetic patients. Acta Physiol Scand 165: 39-44, 1999.
18. Johansson B-L, Sjöberg S, and Wahren J. The influence of human C-peptide on renal function and glucose utilization in Type 1 (insulin-dependent) diabetic patients. Diabetologia 35: 121-128, 1992.
19. Johansson J, Ekberg K, Shafqat J, Henriksson M, Chibalin A, Wahren J, and Jörnvall H. Molecular effects of proinsulin C-peptide. Biochem Biophys Res Commun 295: 1035-1040, 2002.
20. Kunt T, Forst T, Closs E, Wallerath T, Foerstermann U, Lehmann R, Pfuetzner A, Harzer O, Engelbach M, and Berger J. Activation of endothelial nitric oxide synthase (eNOS) by C-peptide (Abstract). Diabetologia 41, Suppl 1: A176, 1998.
21. Lindström K, Johansson C, Johnsson E, and Haraldsson B. Acute effects of C-peptide on the microvasculature of isolated perfused skeletal muscle and kidneys in rat. Acta Physiol Scand 156: 19-25, 1996.
22. Malmberg K, Norhammar A, Wedel H, and Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99: 2626-2632, 1999.
23. Opie L. The Heart. New York: Lippencott-Raven, 1998.
24. Pitkänen O, Nuutila P, Raitakari O, Ronnemaa T, Koskinen P, Iida H, Lehtimaki T, Laine H, Takala T, Viikari J, and Knuuti J. Coronary flow reserve is reduced in young men with IDDM. Diabetes 47: 248-254, 1998.
25. Pitkanen O, Raitakari O, Ronnemaa T, Niinikoski H, Nuutila P, Iida H, Viikari J, and Knuuti J. Influence of cardiovascular risk status on coronary flow reserve in healthy young men. Am J Cardiol 79: 1690-1692, 1997.
26. Pyörälä K, Lakkso M, and Usitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diab Metab Rev 3: 463-524, 1987.
27. Raev D. Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type 1 diabetic patients. Diabetes Care 17: 633-639, 1994.
28. Rigler R, Pramanik A, Jonasson P, Kratz G, Jansson O, Nygren PÅ, Ståhl S, Ekberg K, Johansson BL, Uhlén S, Uhlén M, Jörnvall H, and Wahren J. Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci USA 96: 13318-13323, 1999.
29. 2O production system for heart and brain studies. J Labelled Cpd Radiopharm 44: 1066-1068, 2001.
30. Sobrevia L, Nadal A, Yudilevich D, and Mann G. Activation of L-arginine transport (system y+) and nitric oxide synthase by elevated glucose and insulin in human endothelial cells. J Physiol 490: 775-781, 1996.
31. Sundell J, Laine H, Nuutila P, Ronnemaa T, Luotolahti M, Raitakari O, and Knuuti J. The effects of insulin and short-term hyperglycemia on myocardial blood flow in young men with uncomplicated type 1 diabetes. Diabetologia 45: 775-782, 2002.
32. Sundell J, Nuutila P, Laine H, Luotolahti M, Kalliokoski K, Raitakari O, and Knuuti J. Dose-dependent vasodilating effects of insulin on adenosine-stimulated myocardial blood flow. Diabetes 51: 1125-1130, 2002.
33. Uren N, Melin J, De Bruyne B, Wijns W, Baudhuin T, and Camici P. Relation between myocardial blood flow and the severity of coronary-artery stenosis. New Engl J Med 330: 1782-1788, 1994.
34. Wahren J, Ekberg K, Johansson J, Henriksson M, Pramanik A, Johansson BL, Rigler R, and Jörnvall H. Role of C-peptide in human physiology. Am J Physiol Endocrinol Metab 278: E759-E768, 2000.
35. Vita J, Treasure C, Nabel E, McLenachan J, Fish R, Yeung A, Vekshtein V, Selwyn A, and Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 81: 491-497, 1990.